BAL PHARMA
Back to Balance Sheet
|
BAL PHARMA Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹94 Cr | ₹92 Cr | ₹100 Cr | ₹94 Cr | ₹75 Cr |
What is the latest Sundry Debtors ratio of BAL PHARMA ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹94 Cr |
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹94 Cr |
| Mar2022 | ₹75 Cr |
How is Sundry Debtors of BAL PHARMA Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹94 Cr | 1.29 | |
| Mar2025 | ₹92 Cr | -7.21 | |
| Mar2024 | ₹100 Cr | 6.01 | |
| Mar2023 | ₹94 Cr | 24.78 | |
| Mar2022 | ₹75 Cr | - | |
Compare Sundry Debtors of peers of BAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAL PHARMA | ₹169.1 Cr | 20.1% | 19.2% | 27.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.8% | -3.7% | 17.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 3.4% | 10.1% | 57.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 1.6% | 0.8% | 37.8% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -0.4% | -5.6% | -11.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1.1% | -4.9% | -9.9% | Stock Analytics | |
BAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAL PHARMA | 20.1% |
19.2% |
27.8% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses